151 related articles for article (PubMed ID: 33379285)
1. miRNA Expression Signatures of Therapy Response in Squamous Cell Carcinomas.
Fekete JT; Welker Á; Győrffy B
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33379285
[TBL] [Abstract][Full Text] [Related]
2. Survival associated miRNA signature in patients with head and neck carcinomas.
Yerukala Sathipati S; Ho SY
Heliyon; 2023 Jun; 9(6):e17218. PubMed ID: 37360084
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
[TBL] [Abstract][Full Text] [Related]
4. Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas.
Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
Clin Cancer Res; 2017 Jul; 23(14):3884-3895. PubMed ID: 28143871
[No Abstract] [Full Text] [Related]
5. MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment.
Xu X; Yu S; Sun W; Qin X; Chen Y; Zhou L; Lou R; Dong S; Shen B; Wu J; Zang J; Cao H; Shi M; Zhang Q; Feng J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):431-438. PubMed ID: 29288364
[TBL] [Abstract][Full Text] [Related]
6. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
[TBL] [Abstract][Full Text] [Related]
7. Systemic Investigation Identifying Salivary miR-196b as a Promising Biomarker for Early Detection of Head-Neck Cancer and Oral Precancer Lesions.
Cheng AJ; You GR; Lee CJ; Lu YC; Tang SJ; Huang YF; Huang YC; Lee LY; Fan KH; Chen YC; Huang SF; Chang JT
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441345
[TBL] [Abstract][Full Text] [Related]
8. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
9. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
[TBL] [Abstract][Full Text] [Related]
11. miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma.
Muñoz-Largacha JA; Gower AC; Sridhar P; Deshpande A; O'Hara CJ; Yamada E; Godfrey TE; Fernando HC; Litle VR
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):714-727. PubMed ID: 28495058
[TBL] [Abstract][Full Text] [Related]
12. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.
Wilting SM; Snijders PJ; Verlaat W; Jaspers A; van de Wiel MA; van Wieringen WN; Meijer GA; Kenter GG; Yi Y; le Sage C; Agami R; Meijer CJ; Steenbergen RD
Oncogene; 2013 Jan; 32(1):106-16. PubMed ID: 22330141
[TBL] [Abstract][Full Text] [Related]
13. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
14. A Novel Signature for Predicting Prognosis of Smoking-Related Squamous Cell Carcinoma.
Chen C; Cheng X; Li S; Chen H; Cui M; Bian L; Jin H
Front Genet; 2021; 12():666371. PubMed ID: 33968141
[TBL] [Abstract][Full Text] [Related]
15. The Expression and Effection of MicroRNA-499a in High-Tobacco Exposed Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
Gong SQ; Xu M; Xiang ML; Shan YM; Zhang H
Front Oncol; 2019; 9():678. PubMed ID: 31417866
[No Abstract] [Full Text] [Related]
16. Epigenetic Field Cancerization in Gastric Cancer: microRNAs as Promising Biomarkers.
Pereira AL; Magalhães L; Moreira FC; Reis-das-Mercês L; Vidal AF; Ribeiro-Dos-Santos AM; Demachki S; Anaissi AKM; Burbano RMR; Albuquerque P; Dos Santos SEB; de Assumpção PP; Ribeiro-Dos-Santos ÂKC
J Cancer; 2019; 10(6):1560-1569. PubMed ID: 31031866
[No Abstract] [Full Text] [Related]
17. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
Wang XJ; Zeng B; Lin S; Chen M; Chi P
Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
[TBL] [Abstract][Full Text] [Related]
18. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
Yang Y; Mei Q
Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
[TBL] [Abstract][Full Text] [Related]
19. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
Zhang HM; Yang B; Chen HF; Chi XH; Xi YB; Chen XM; Guo B; He PF; Lu XC
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jun; 34(6):530-535. PubMed ID: 31032588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
